These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 2239489)

  • 1. Reappraising the exteriorization of the mammalian testes through evolutionary physiology.
    Miller WB; Torday JS
    Commun Integr Biol; 2019; 12(1):38-54. PubMed ID: 31143362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Evolution of the Mammalian Brain.
    Torday JS; Miller WB
    Front Syst Neurosci; 2016; 10():31. PubMed ID: 27147985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life Is Simple-Biologic Complexity Is an Epiphenomenon.
    Torday JS
    Biology (Basel); 2016 Apr; 5(2):. PubMed ID: 27128951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A central theory of biology.
    Torday JS
    Med Hypotheses; 2015 Jul; 85(1):49-57. PubMed ID: 25911556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?
    Müller T; Kuhn W; Przuntek H
    J Neural Transm Gen Sect; 1993; 92(2-3):187-95. PubMed ID: 8369108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Parkinson's disease with COMT inhibitors].
    Shabtai H; Korczyn A
    Harefuah; 2001 Oct; 140(10):935-7. PubMed ID: 11681127
    [No Abstract]   [Full Text] [Related]  

  • 7. Microplate screening assay to identify inhibitors of human catechol-O-methyltransferase.
    Kurkela M; Siiskonen A; Finel M; Tammela P; Taskinen J; Vuorela P
    Anal Biochem; 2004 Aug; 331(1):198-200. PubMed ID: 15246016
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased erythrocyte catechol-O-methyltransferase activity in elderly: relationship to clinical peculiarities in Parkinson's disease?
    Maltête D; Edouard T; Mihout B; Costentin J
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):323-4. PubMed ID: 20148410
    [No Abstract]   [Full Text] [Related]  

  • 9. [What strategies are recommended for early stage disease? Other treatments].
    Damier P
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():105-8. PubMed ID: 10916044
    [No Abstract]   [Full Text] [Related]  

  • 10. Catechol-O-methyltransferase and its role in catecholamine metabolism.
    Nic a' Bháird N; Goldberg R; Tipton KF
    Adv Neurol; 1990; 53():489-95. PubMed ID: 2239489
    [No Abstract]   [Full Text] [Related]  

  • 11. New drugs in the treatment of Parkinson's disease. An introduction.
    Bracco F
    Adv Neurol; 1996; 69():513-7. PubMed ID: 8615173
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.